Clinical relevance of clonal hematopoiesis in persons aged ≥80 years
Marianna Rossi(Istituti di Ricovero e Cura a Carattere Scientifico), Gastone Castellani(University of Bologna), Francesco Passamonti(University of Milan), Lucio Morabito(Istituti di Ricovero e Cura a Carattere Scientifico), Gianluigi Condorelli(Humanitas University), Rosanna Asselta(Humanitas University), Pierre Fenaux(Saint Louis University Hospital), Paolo Detoma(Ospedale degli Infermi), Nicla Manes(Wellcome Sanger Institute), Alessia Campagna(Humanitas University), Sara Mandelli(Mario Negri Institute for Pharmacological Research), Matteo Zampini(IRCCS Humanitas Research Hospital), Emma Riva(Mario Negri Institute for Pharmacological Research), Alessia Antonella Galbussera(Mario Negri Institute for Pharmacological Research), Erica Travaglino(Policlinico San Matteo Fondazione), Chiara Milanesi(Istituti di Ricovero e Cura a Carattere Scientifico), Luca Sala(Ospedale degli Infermi), Marilena Bicchieri(Humanitas University), Claudia Sala, Manja Meggendorfer(Université Paris-Sud), Efrem Civilini(Humanitas University), Cristina Astrid Tentori(Humanitas University), Roberto Zanetti(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Giovanni Corrao(University of Milan), Rocco Piazza(Azienda Ospedaliera San Gerardo), Stefano Duga(Humanitas University), Matteo Bersanelli(Humanitas University), Niccolò Bolli(University of Milan), Giulia Soldà(Humanitas University), Elena Saba(Istituti di Ricovero e Cura a Carattere Scientifico), Karolina Malik(Universität Hamburg), Paola Allavena(IRCCS Humanitas Research Hospital), Aurelio Malabaila(Ospedale degli Infermi), Alberto Termanini(Istituti di Ricovero e Cura a Carattere Scientifico), Maria De Santis(Medical University of Vienna), Clelia Peano(Humanitas University), Marta Ubezio(Humanitas University), Chiara Chiereghin(Istituti di Ricovero e Cura a Carattere Scientifico), Claudia Saitta(Istituti di Ricovero e Cura a Carattere Scientifico), Uwe Platzbecker(National Center for Tumor Diseases), Mauro Tettamanti(Mario Negri Institute for Pharmacological Research), Françesc Solé(Fundación Josep Carreras Contra la Leucemia), Laura Giordano(Istituti di Ricovero e Cura a Carattere Scientifico), Ettore Mosca(Construction Technologies Institute), Giulia Maggioni(Humanitas University), Stefano Rosso(Piedmont Reference Center for Epidemiology and Cancer Prevention), Armando Santoro(IRCCS Humanitas Research Hospital), Elena Riva(Humanitas University), Antonio Russo(Humanitas University), Carlo Selmi(University of Milan)
Cited by 72
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
The chemokine system in diverse forms of macrophage activation and polarization
|Trends in Immunology|2004|6.5k
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes
|Trends in Immunology|2002|5.5k
Genomic Classification and Prognosis in Acute Myeloid Leukemia
|New England Journal of Medicine|2016|4.4k